To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

DRUG LAWSUIT

TODAY'S HEADLINES

J&J's antibiotic faces $800M lawsuit

A new $800 million racketeering lawsuit alleges that Johnson & Johnson hid information about the devastating side effects of its antibiotic. Read more

New chemo drug extends survival

First chemotherapy drug to extend survival approved for liposarcoma. Read more

CONTINUING PHARMACY EDUCATION

LAW: Primer on biosimilar agents

This month's CE activity is open for pharmacists and pharmacy technicians, "LAW: Primer on biosimilar agents." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE law credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Huge coalition to advance cancer treatments

Major pharma companies and insurers announced that they would work together to advance combination drugs and genome sequencing for patients with cancer. Details

February 3, 2016

Related Articles

Valeant responds to drug price concerns with cuts

First chemotherapy antidote available soon

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us